Millions of people have used Ozempic and similar drugs to lose weight, but are unhappy with the way their faces change, leading some to turn to a non-surgical treatment to flesh out their cheeks again ...
It's been an excellent year for Viking Therapeutics (NASDAQ: VKTX), a mid-cap biotech company. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported ...